These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30336533)

  • 1. MiR-33 may be a Biological Marker for Coronary Heart Disease.
    Xie Z; Ma P
    Clin Lab; 2018 Oct; 64(10):1755-1760. PubMed ID: 30336533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Plasma miR-144 as a Novel Biomarker for Coronary Artery Disease.
    Chen B; Luo L; Wei X; Gong D; Jin L
    Ann Clin Lab Sci; 2018 Jul; 48(4):440-445. PubMed ID: 30143484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of miR-126 and its potential function in coronary artery disease.
    Wang X; Lian Y; Wen X; Guo J; Wang Z; Jiang S; Hu Y
    Afr Health Sci; 2017 Jun; 17(2):474-480. PubMed ID: 29062343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miR-106a may Function as Potential Biomarkers in Patients with Coronary Artery Disease.
    Ding H; Hu CX; Xu JK
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease.
    Li H; Gao F; Wang X; Wu J; Lu K; Liu M; Li R; Ding L; Wang R
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064817
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma miR-208b and miR-499: Potential Biomarkers for Severity of Coronary Artery Disease.
    Wang W; Li T; Gao L; Li Y; Sun Y; Yao HC
    Dis Markers; 2019; 2019():9842427. PubMed ID: 31885748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between plasma levels of microRNA-126 and coronary collaterals in patients with coronary artery disease].
    Nie X; Su L; Zhou Y; Zhao Y; Shi D; Liu Y; Zhou Z; Zhou Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jul; 42(7):561-5. PubMed ID: 25327597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris.
    Li HY; Zhao X; Liu YZ; Meng Z; Wang D; Yang F; Shi QW
    Cell Physiol Biochem; 2016; 39(3):837-46. PubMed ID: 27497911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of plasma miR-503 and coronary collateral circulation in patients with coronary artery disease.
    Fei Y; Hou J; Xuan W; Zhang C; Meng X
    Life Sci; 2018 Aug; 207():145-151. PubMed ID: 29870767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.
    Wang X; Chen LL; Zhang Q
    Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum YKL-40 level positively correlates with coronary artery disease.
    Jin Y; Cao JN; Wang CX; Feng QT; Ye XH; Xu X; Yang CJ
    Biomark Med; 2017 Feb; 11(2):133-139. PubMed ID: 28097894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.
    Dong J; Liang YZ; Zhang J; Wu LJ; Wang S; Hua Q; Yan YX
    J Atheroscler Thromb; 2017 Apr; 24(4):430-441. PubMed ID: 27629254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease.
    Kumar D; Narang R; Sreenivas V; Rastogi V; Bhatia J; Saluja D; Srivastava K
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32033332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease.
    Amr KS; Abdelmawgoud H; Ali ZY; Shehata S; Raslan HM
    Br J Biomed Sci; 2018 Apr; 75(2):82-87. PubMed ID: 29452547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
    Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
    Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients.
    Ali Sheikh MS; Xia K; Li F; Deng X; Salma U; Deng H; Wei Wei L; Yang TL; Peng J
    Biomed Res Int; 2015; 2015():740301. PubMed ID: 25664324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neoangiogenesis and coronary atherosclerosis: diagnostic value of a novel biochemical marker placenta growth factor in patients with ischemic heart disease].
    Shevchenko AO; Shevchenko OP; Orlova OV; Tulikov MV
    Kardiologiia; 2006; 46(11):9-15. PubMed ID: 17159877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-15a Functions as a Diagnostic Biomarker for Coronary Artery Disease.
    Pan X; He Y; Ling S; Chen Z; Yan G
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.
    Satoh M; Takahashi Y; Tabuchi T; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Apr; 128(8):483-91. PubMed ID: 25385173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between elevated plasma microRNA-223 content and severity of coronary heart disease.
    Guo JF; Zhang Y; Zheng QX; Zhang Y; Zhou HH; Cui LM
    Scand J Clin Lab Invest; 2018 Sep; 78(5):373-378. PubMed ID: 29888618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.